MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of TremfyaR Guselkumab for Treatment of Adults with Active Psoriatic Arthritis

MorphoSys&39;s Licensee Janssen Submits Biologics License Application to U.S. FDA of TremfyaR Guselkumab for Treatment of Adults with Active Psoriatic ArthritisPLANEGG MUNICH GERMANY ACCESSWIRE September 16 2019 MorphoSys AG FSEMOR; Prime Standard ...